Association of androgenetic alopecia with metabolic syndrome in men: A community-based survey

British Journal of Dermatology

Volumn 163, Issue 2, 2010, Pages 371-377

  Su, L H ^a   Chen, T H H ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

alopecia; cardiovascular disease; diabetes mellitus; metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FAMILY HISTORY; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TAIWAN;

ADULT; AGE FACTORS; AGED; ALOPECIA; CHOLESTEROL; CROSS-SECTIONAL STUDIES; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; TAIWAN; TRIGLYCERIDES;

EID: 77954868078     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09816.x     Document Type: Article

References (33)

1. Matilainen VA, Makinen PK, Keinanen-Kiukaanniemi SM. Early onset of androgenetic alopecia associated early severe coronary heart disease: a population-based, case-control study. J Cardiovasc Risk 2001 8 : 147 151.
2. Rebora A. Baldness and coronary artery disease. Arch Dermatol 2001 137 : 943 947.
3. Lotufo PA, Chae CU, Ajani UA et al. Male pattern baldness and coronary heart disease. Arch Intern Med 2000 160 : 165 171.
4. Trevisan M, Farinaro E, Krogh V et al. Baldness and coronary heart disease risk factors. J Clin Epidemiol 1993 46 : 1213 1218.
5. Cooke NT. Male-pattern alopecia and coronary artery disease in men. Br J Dermatol 1979 101 : 455 458.
6. Sasmaz S, Senol M, Ozcan A et al. The risk of coronary heart disease in men with androgenetic alopecia. J Eur Acad Dermatol Venereol 1999 12 : 123 125.
7. Matilainen VA, Koskela P, Keinanen-Kiukaanniemi SM. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000 356 : 1165 1166.
8. Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol 2007 17 : 220 222.
9. Sadighha A, Zahed GM. Evaluation of lipid levels in androgenetic alopecia in comparison with control group. J Eur Acad Dermatol Venereol 2009 23 : 80 1.
10. González-González JG, Mancillas-Adame LG, Fernández-Reyes M et al. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol (Oxf) 2009 71 : 494 499.
11. Cotton SG, Nixon JM, Carpenter RG et al. Factors discriminating men with coronary heart disease from healthy controls. Br Heart J 1972 34 : 458 464.
12. Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA 1993 269 : 998 1003. (Pubitemid 23066636)
13. Herrera CR, Agostino RB, Gerstman BB et al. Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol 1995 142 : 828 833.
14. Ford ES, Freedman DS, Byers T. Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol 1996 143 : 651 657.
15. Ellis JA, Stebbing M, Harrap SB. Male pattern baldness is not associated with established cardiovascular risk factors in the general population. Clin Sci 2001 100 : 401 404.
16. Ellis JA, Stebbing M, Harrap SB. Insulin gene polymorphism and premature male pattern baldness in the general population. Clin Sci 1999 96 : 659 662.
17. Shahar E, Heiss G, Rosamond WD, Szklo M. Baldness and myocardial infarction in men. Am J Epidemiol 2008 167 : 676 683.
18. Dogramaci AC, Balci DD, Karazincir S et al. Is androgenetic alopecia a risk for atherosclerosis? J Eur Acad Dermatol Venereol 2009 23 : 673 677.
19. Cornier MA, Dabelea D, Hernandez TL et al. The metabolic syndrome. Endocr Rev 2008 29 : 777 822.
20. Alexander CM, Landsman PB, Teutsch SM et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003 52 : 1210 1214.
21. Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006 91 : 2906 2912.
22. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006 47 : 1093 1100.
23. Chen THH, Chiu YH, Luh DL et al. Taiwan Community-Based Integrated Screening Group. Community-based multiple screening model: design, implementation, and analysis of 42 387 participants. Cancer 2004 100 : 1734 1743.
24. Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975 68 : 1359 1365.
25. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977 97 : 247 254.
26. Norwood OT, Lehr B. Female androgenetic alopecia: a separate entity. Dermatol Surg 2000 26 : 679 682.
27. Yazdabadi A, Magee J, Harrison S, Sinclair R. The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unit. Br J Dermatol 2008 159 : 1300 1302.
28. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
29. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment.
30. Su LH, Chen THH. Association of androgenetic alopecia with smoking and its prevalence among Asian men. Arch Dermatol 2007 143 : 1401 1406.
31. Xu F, Sheng YY, Mu ZL et al. Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study. Br J Dermatol 2009 160 : 629 632.
32. Guarrera M, Cardo P, Arrigo P, Robera A. Reliability of Hamilton-Norwood classification. Int J Tricol 2009 1 : 120 122.
33. Severi G, Sinclair R, Hopper JL et al. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol 2003 149 : 1207 1213.